Market Overview

Why Unum Therapeutics Is Trading Higher Today

Why Unum Therapeutics Is Trading Higher Today

Unum Therapeutics Inc (NASDAQ: UMRX) shares are trading higher on Tuesday after Wedbush upgraded the stock from Neutral to Overweight and raised its target price from $1 to $4.

Unum Therapeutics Inc is a U.S. based clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer.

Unum Therapeutics Inc shares were trading up 4.09% at $2.29 at time of publication on Tuesday. The stock has a 52-week high of $3.40 and a 52-week low of 30 cents.

Latest Ratings for UMRX

Jul 2020WedbushUpgradesNeutralOutperform
Mar 2020H.C. WainwrightMaintainsBuy
Mar 2020WedbushDowngradesOutperformNeutral

View More Analyst Ratings for UMRX
View the Latest Analyst Ratings


Related Articles (UMRX)

View Comments and Join the Discussion!

Posted-In: why it's movingPenny Stocks Upgrades Price Target Analyst Ratings

Latest Ratings

APAB of A SecuritiesMaintains23.0
COPB of A SecuritiesMaintains46.0
CXOB of A SecuritiesMaintains65.0
DVNB of A SecuritiesMaintains18.0
EOGB of A SecuritiesMaintains64.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at